אודות פרק זה
4basebio PLC (AIM:4BB, FRA:8L7, ETR:88Q) CEO Amy Walker joined Proactive's Stephen Gunnion to discuss the company's synthetic DNA platform, growing commercial momentum and key milestones for investors.
Walker explained how 4basebio's enzyme-based technology provides a cleaner, faster and more cost-effective alternative to conventional plasmid DNA manufacturing, supporting applications in cell and gene therapy, vaccines and gene editing. She also highlighted the launch of the company's single-stranded DNA product, which offers lower toxicity and the ability to produce longer DNA molecules for advanced gene editing.
The interview also covers a recent Phase 2 clinical supply agreement, the appointment of mRNA expert Jeff Coller to the Strategic Advisory Board, expansion of the company's Cambridge manufacturing facility and the commercial milestones investors should watch for over the coming months.
For more interviews and market insights, visit Proactive's YouTube channel. Don't forget to like this video, subscribe to the channel and enable notifications so you never miss future content.
#4basebio #SyntheticDNA #DNAManufacturing #GeneEditing #CRISPR #CellTherapy #GeneTherapy #Biotech #Biotechnology #LifeSciences #mRNA #Vaccines #PersonalizedMedicine #CancerVaccines #HealthcareInnovation #ClinicalTrials #CambridgeBiotech #Investing #SmallCapStocks #ProactiveInvestors
Walker explained how 4basebio's enzyme-based technology provides a cleaner, faster and more cost-effective alternative to conventional plasmid DNA manufacturing, supporting applications in cell and gene therapy, vaccines and gene editing. She also highlighted the launch of the company's single-stranded DNA product, which offers lower toxicity and the ability to produce longer DNA molecules for advanced gene editing.
The interview also covers a recent Phase 2 clinical supply agreement, the appointment of mRNA expert Jeff Coller to the Strategic Advisory Board, expansion of the company's Cambridge manufacturing facility and the commercial milestones investors should watch for over the coming months.
For more interviews and market insights, visit Proactive's YouTube channel. Don't forget to like this video, subscribe to the channel and enable notifications so you never miss future content.
#4basebio #SyntheticDNA #DNAManufacturing #GeneEditing #CRISPR #CellTherapy #GeneTherapy #Biotech #Biotechnology #LifeSciences #mRNA #Vaccines #PersonalizedMedicine #CancerVaccines #HealthcareInnovation #ClinicalTrials #CambridgeBiotech #Investing #SmallCapStocks #ProactiveInvestors
אנגלית
ארצות הברית
תעתיק 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
חיפוש פרקים ישנים
חפש פרקים קודמים של Proactive - Interviews for investors.
פרקים אחרים בפודקאסט הזה
Great Red Lake Gold Corp Chief Financial Officer Brian Morales joined Steve Darling from Proactive to discuss the company's move into copper exploration, its acquisition of the Bilton-Brown property in Ontario and plans to advance the project toward a potential drilling program in 2027.
Morales e…
Resolution Minerals Ltd US operations chief executive Craig Lindsay talked with Proactive about the latest drilling results from the company’s 100%-owned Horse Heaven Project in Idaho, where Golden Gate North has developed into a broad gold-mineralised system extending for at least 500 metres.
Li…
archTIS CEO and managing director Daniel Lai talked with Proactive about the cybersecurity company's record September quarter, progress toward operating cash flow break-even, ongoing negotiations with the US Department of Defense and the growth opportunities emerging from artificial intelligence.
…
Recce Pharmaceuticals Ltd managing director and CEO James Graham talked with Proactive about the company’s exclusive licensing and commercialisation agreement with Arrotex Pharmaceuticals for RECCE® 327 topical gel (R327G) in Australia and New Zealand.
Graham described the agreement as a signific…
FireFly Metals Ltd managing director Steve Parsons talked with Proactive about the company’s latest copper-gold discovery at the Mount Joy prospect within the Green Bay Project in Newfoundland, Canada, and the wider regional exploration program underway around the proposed Ming Mine restart.
Pars…
הצהרה: הפודקאסט והגרפיקה המוטבעים בדף זה הם מ-Proactive, שהוא רכושו של בעליו ואינו קשור או מאושר על ידי Listen Notes, Inc.
